1. Genetics of type III hyperlipoproteinemia
- Author
-
Jürgen M Dobmeyer, Susanne Piesch, Christine Fischer, and Giso Feussner
- Subjects
Adult ,Male ,Apolipoprotein E ,Heterozygote ,medicine.medical_specialty ,Apolipoprotein B ,Epidemiology ,Lipoproteins ,Hyperlipidemias ,Familial hypercholesterolemia ,Statistics, Nonparametric ,Apolipoproteins E ,Gene Frequency ,Internal medicine ,Hyperlipoproteinemia Type III ,Hyperlipidemia ,medicine ,Humans ,Genetics (clinical) ,Aged ,Genetics ,biology ,Homozygote ,Hypertriglyceridemia ,nutritional and metabolic diseases ,Middle Aged ,medicine.disease ,Pedigree ,Familial hypertriglyceridemia ,Lipoprotein Lipase ,Endocrinology ,Mutation ,biology.protein ,Female ,lipids (amino acids, peptides, and proteins) ,Lipoprotein disorder ,Isoelectric Focusing ,Dyslipidemia - Abstract
One hundred forty-seven relatives of 43 patients with "classical" type III hyperlipoproteinemia (HLP) having the apolipoprotein (apo) E2/2 phenotype were studied to determine the occurrence of hyperlipidemia and the presence of further possible genes for lipoprotein disorders in these families. In 12 pedigrees primary dyslipidemia was prevalent among patients and respective blood-relatives. In these kindreds the coexistent presence of genes for familial combined hyperlipidemia (n = 6), familial hypertriglyceridemia (n = 5), and familial hypercholesterolemia (n = 1), respectively, was supposed. Our results, therefore, confirm and extend previous data on the multifactorial genesis of the diseases. Besides homozygosity for a receptor binding-defective isoform of apo E (apo E2), additional genes for familial lipoprotein disorders might operate in the pathogenesis of type III HLP. This is the largest family study performed so far in this primary lipoprotein disorder.
- Published
- 1997
- Full Text
- View/download PDF